Cargando…
Discovery of selective inhibitors of Glutaminase-2, which inhibit mTORC1, activate autophagy and inhibit proliferation in cancer cells
Glutaminase, which converts glutamine to glutamate, is involved in Warburg effect in cancer cells. Two human glutaminase genes have been identified, GLS (GLS1) and GLS2. Two alternative transcripts arise from each glutaminase gene: first, the kidney isoform (KGA) and glutaminase C (GAC) for GLS; and...
Autores principales: | Lee, Yue-Zhi, Yang, Cheng-Wei, Chang, Hsin-Yu, Hsu, Hsing-Yu, Chen, Ih-Shen, Chang, Hsun-Shuo, Lee, Chih-Hao, Lee, Jinq-chyi, Kumar, Chidambaram Ramesh, Qiu, Ya-Qi, Chao, Yu-Sheng, Lee, Shiow-Ju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171615/ https://www.ncbi.nlm.nih.gov/pubmed/25026281 |
Ejemplares similares
-
Retraction for Li et al., Synthetic lethality of combined glutaminase and Hsp90 inhibition in mTORC1-driven tumor cells
Publicado: (2023) -
Effects of mTORC1 inhibition on proteasome activity and levels
por: Park, Seo Hyeong, et al.
Publicado: (2022) -
Identification of anti-viral activity of the cardenolides, Na(+)/K(+)-ATPase inhibitors, against porcine transmissible gastroenteritis virus
por: Yang, Cheng-Wei, et al.
Publicado: (2017) -
Towards specific inhibition of mTORC2
por: Murray, Elizabeth R., et al.
Publicado: (2017) -
Rapamycin inhibits mSin1 phosphorylation independently of mTORC1 and mTORC2
por: Luo, Yan, et al.
Publicado: (2015)